Lexicon pharmaceuticals reports phase3 study for sotagliflozin in patients with type 1 diabetes
Lexicon Pharmaceuticals announced additional positive data from the Phase 3 inTandem1 study. ...
Milestone Pharma Announces Etripamil Phase 2 Clinical Program Success for the Treatment of PSVT
Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular compan announced positive data from its Phase 2 NODE-1 trial evaluating etripamil, a novel, potent,...
JSR Life Sciences Expands Amsphere A3 Production Capacity
JSR Life Sciences (JLS), the global life sciences focused division of JSR Corporation, today announced plans for expansion of its production capabilities of Amsphere™...
Corline Biomedical AB Corline received orphan drug status in the US
Corline Biomedical AB has received notification from the US FDA , the company's heparin ingredient granted orphan drug status in the US for the...
Cannabics Pharmaceuticals Announces Scientific Collaboration With A Leading CTC European Lab
Cannabics Pharmaceuticals Inc announced it has begun a scientific collaboration with a medical laboratory in Europe, a world leader in the field of CTC...
Poxel Announces Positive Top Line Results for Imeglimin Phase 2b Study for Type 2 Diabetes
POXEL SA , a biopharmaceutical company focused on the development of innovative drugs to treat metabolic diseases, including type 2 diabetes, announced today positive...
Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)
Takeda Pharmaceutical Company Limited announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...